Showing posts with label Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS). Show all posts
Showing posts with label Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS). Show all posts
Saturday, January 6, 2024

FDA Approves Joenja (leniolisib) for the Treatment of Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS)

›
Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announced the USFDA  approval...